...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Vascular and endovascular surgery >Impact of endoluminal treatment on small abdominal aortic aneurysm: aneurysm sac regression and secondary interventions with 5 years of follow-up.
【24h】

Impact of endoluminal treatment on small abdominal aortic aneurysm: aneurysm sac regression and secondary interventions with 5 years of follow-up.

机译：腔内治疗对小腹主动脉瘤的影响：随访5年，对动脉瘤囊进行消退和二次干预。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Does early repair of small abdominal aortic aneurysms (AAAs) lead to faster aneurysm sac regression or less secondary intervention? Computed tomography scans and reconstructions from M2S of all patients undergoing endovascular AAA repair at our institution from 1996 to 2006 were retrospectively reviewed. A small aneurysm is defined as an aneurysm sac to renal diameter ratio of less than 2. There were 374 patients with endovascular AAA repair that had complete imaging studies. There were 75 patients (20%) with small AAAs; of those, 19 patients (25.3%) had endoleak compared with 108 patients (36.1%) with a large aneurysm ( P .1). Over a mean follow-up time of 42 months (range, 1-109), 11 small AAAs (14.7%) had secondary interventions compared with 58 (19.4%) of the large AAAs (P .41). Small AAAs at 5 years had a 2.5% volume sac regression but a 3.0% increase in diameter. Those with a large aneurysm had a slight increase in sac volume and diameter at 1 month (3.3%, 1.4%) and then steadily decreased to -13.4% and -8.8% at 5 years. Patients with Endologix (Endologix Inc., Irvine, Calif) devices have the most regression when compared with patients with AneuRx (Medtronic Inc., Minneapolis, Minn) and Talent (Medtronic Inc., Minneapolis, Minn) devices. Early endovascular intervention in small AAAs does not result in faster aneurysm sac regression or secondary intervention. Aneurysm sac regression is significantly affected by endoleak, aneurysm size, and device used.
机译：早期修复小腹主动脉瘤（AAAs）是否会导致更快的动脉瘤囊消退或较少的二次干预？回顾性地回顾了1996年至2006年间我院接受血管内AAA修复的所有患者的计算机断层扫描和M2S重建。小动脉瘤的定义是动脉瘤囊与肾脏直径之比小于2。有374例接受血管内AAA修复的患者接受了完整的影像学检查。有75例（20％）小型AAA患者;在这些患者中，有19例（25.3％）发生了内漏，而大动脉瘤的108例（36.1％）（P .1）。在平均随访时间42个月（范围1-109）中，有11个小型AAA（14.7％）接受了二次干预，而大型AAA中有58个（19.4％）接受了二级干预（P = 41）。 5年的小型AAA的囊囊体积缩小了2.5％，直径增大了3.0％。具有大动脉瘤的患者在1个月时囊体积和直径略有增加（3.3％，1.4％），然后在5年时稳定下降至-13.4％和-8.8％。与使用AneuRx（Medtronic Inc.，明尼阿波利斯，明尼苏达州）和Talent（Medtronic Inc.，明尼阿波利斯，明尼苏达州）设备的患者相比，使用Endologix（Endologix Inc.，尔湾，加利福尼亚州）设备的患者的回归最大。小型AAA的早期血管内介入治疗不会导致更快的动脉瘤囊消退或二次介入治疗。内囊渗漏，动脉瘤大小和所用器械显着影响动脉瘤囊的消退。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号